Based on results of the PINES trial, have you shifted your practice to start treatment for newly diagnosed pediatric ITP with eltrombopag?

I would answer this, "yes and no." As many readers will already know, the PINES trial (Shimano et al., PMID 41123939) was a randomized trial of pediatric patients, between eltrombopag and standard care, in a 2:1 ratio, in newly diagnosed ITP and non-severe bleeding, who required pharmacologic therap...